---
title: "CASI Pharmaceuticals says SVP Wei (Larry) Zhang steps down"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295843763.md"
description: "CASI Pharmaceuticals announced that Senior Vice President Wei (Larry) Zhang is stepping down from his role. This personnel change is part of the company's broader efforts to streamline its branches, personnel, and related activities within the United States."
datetime: "2026-08-13T20:38:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295843763.md)
  - [en](https://longbridge.com/en/news/295843763.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295843763.md)
generator: "portal-rs"
---

# CASI Pharmaceuticals says SVP Wei (Larry) Zhang steps down

-   CASI Pharmaceuticals reported that Wei (Larry) Zhang will no longer serve as senior vice president. \* The move was tied to efforts to streamline branches, personnel, and related activities in the United States. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CASI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-095969), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CASIF.US](https://longbridge.com/en/quote/CASIF.US.md)
- [CASI.US](https://longbridge.com/en/quote/CASI.US.md)

## Related News & Research

- [4,000 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by JW Asset Management LLC](https://longbridge.com/en/news/298374596.md)
- [CASI Pharmaceuticals sells Alesta stake to BioMarin for US$5.9 million](https://longbridge.com/en/news/297773958.md)
- [Ligand CLO, Secretary Andrew Reardon sells USD 1.43 million in common shares](https://longbridge.com/en/news/298372033.md)
- [CRMD: Strong revenue growth, pipeline expansion, and financial flexibility drive continued value creation](https://longbridge.com/en/news/298461323.md)
- [AN2 Therapeutics director Robin Shane Readnour reports disposal of common shares worth $97,645.76](https://longbridge.com/en/news/298375908.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**